|
1）Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No.5, version 2.0 IARC oress, Lyon, 2004
|
|
|
|
|
2）厚生労働省大臣官房統計情報部．人口動態統計．厚生労働省ホームページ．http://www.mhlw.go.jp/toukei/saikin/index.html
|
|
|
|
|
|
3）Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet. 2005; 366: 1303-14
|
|
|
|
|
4）Ishiguro S, Inoue M, Kurahashi N, et al. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study): with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Cause Control. 2008; 19: 33-41
|
|
|
|
|
|
5）Randi G, Franceschi S, Vecchia CL. Gallbladder cancer world wide: Geographical distibution and risk factors. Int J Cancer. 2006; 118: 1591-602
|
|
|
|
|
|
6）Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012; 57: 69-76
|
|
|
|
|
|
7）Jing W, Jin G, Zhou X, et al. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev. 2012; 21: 24-31
|
|
|
|
|
|
8）Calle EE, Rodriquez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-38
|
|
|
|
|
|
9）Kuriyama S, Tsubono Y, Hozawa A, et al. Obesity and risk of cancer in Japan. Int J Cancer. 2005; 113: 148-57
|
|
|
|
|
|
10）Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007; 96: 457-461
|
|
|
|
|
|
11）厚生労働省．「印刷事業場で発生した胆管がんの業務上外に関する検討会」報告書．化学物質ばく露と胆管がん発症との因果関係について～大阪の印刷事業場の症例からの検討～．2013
|
|
|
|
|
|
12）IARC monographs on the evaluation of carcinogen risks to human volume 71, Re-evaluation of some organic chemical hydrazine, and hydrogen peroxide. 1999
|
|
|
|
|
|
13）Sherratt PJ, Williams S, Foster J, et al. Direct comparison of the nature of mouse and human GST T1-1 and the implications on dichloromethane carcinogenicity. Toxicol Appl Pharmacol. 2002; 179: 89-97
|
|
|
|
|
|
14）Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996; 347: 444-5
|
|
|
|
|
|
15）Alvaro D, et al. Estrogen and insulin-like growth factor1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol. 2006; 877-88
|
|
|
|
|
|
16）Gallagher EJ, LeRoith D. IGF, insulin, and cancer. Endocrinology. 2011; 152: 2546-51
|
|
|
|
|
|
17）川本 徹，他．胆道癌におけるIGFRとRaf-1の発現と臨床病理学的因子との関連性．胆道．2009; 23: 469
|
|
|
|
|
18）Alvaro D, Barbaro B, Franchitto A, et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol. 2006; 169: 877-88
|
|
|
|
|